Small-Cap Value ETF Showdown: Vanguard's VBR vs. the State Street SLYV

Vanguard Morningstar Small-Cap Value ETF (VBR) is the cheaper option with a 0.05% expense ratio versus 0.15% for State Street’s S&P 600 Small Cap Value ETF (SLYV), while both show similar dividend yields (~1.7%-1.8%). Over the trailing year, SLYV outperformed at 32.4% total return vs VBR’s 24.3%, but VBR has slightly lower 5-year max drawdown (-24.2% vs -28.7%) and is more diversified (841 vs 461 holdings). With larger AUM ($68.3B vs $5.1B) and nearly identical trailing-12-month payouts ($4.32/share vs $1.98/share), the article frames VBR as the better fit for cost and diversification, despite less 1-year relative performance.

Analysis

This is more a wrapper-choice story than a fundamental alpha event. The only durable edge here is structural: lower fees and deeper liquidity tend to win in model portfolios, so VBR should keep compounding share in core allocations even if SLYV screens “purer” on factor purity. The spread is small enough that the winner is usually determined by implementation constraints, not stock selection skill.

From a market-mechanics standpoint, VBR’s broader basket dilutes idiosyncratic blowups in names like PAYC, MTCH, and JXN, which matters if small-cap value remains choppy or credit conditions tighten. SLYV’s narrower, more S&P-style construction should show higher factor beta in a clean value/reflation tape, but that also means more sensitivity to financials and cyclicals if growth slows. In other words, SLYV is the better tactical vehicle for a late-cycle value rally; VBR is the better core sleeve for minimizing fee drag and unintended concentration.

The consensus misses how little of this is about current headline performance and how much is about path dependency. After a strong 1-year run in small-cap value, marginal buyers are likely to prioritize liquidity and tracking consistency, which is a tailwind for VBR over a 6-18 month horizon. The main falsifier for a VBR-over-SLYV preference is a renewed breakout in deep-value cyclicals and financials over the next 1-3 quarters, especially if rate cuts steepen the curve and restore earnings momentum to banks, insurers, and other balance-sheet-sensitive holdings.

Key Decisions for Investors

• Core allocation: prefer VBR over SLYV for passive small-cap value exposure over a 6-18 month horizon; the fee and liquidity advantage should dominate if the objective is efficient beta capture.
• Tactical pair: long SLYV / short VBR only if you expect a strong rebound in deep-value cyclicals and financials over the next 1-3 quarters; otherwise the fee and diversification gap argues against paying for the purer factor exposure.
• Watchlist: monitor MTCH, PAYC, and JXN as high-beta underlying exposure points; if earnings revisions weaken, SLYV should underperform VBR faster because its basket is more concentration-sensitive.
• No-trade alert: if small-cap credit spreads widen or regional bank stress reappears, avoid adding to SLYV; the higher concentration in financials raises downside asymmetry versus VBR.
• Implementation idea: use VBR as the default ETF in advisor/client sleeves, and reserve SLYV for tactical factor trades around rate-cut or reflation windows where small-cap value leadership is likely to broaden.